This review reveals significant gaps in understanding inflammatory markers in sickle cell disease and COVID-19 interactions, emphasizing their complex implications.
Key Points
Significant knowledge gaps exist concerning inflammatory markers in the context of sickle cell disease and COVID-19.
The cytokine storm phenomenon underscores the dangerous intersection of chronic inflammation and acute responses in patients.
Analysis highlights complications like hyperhaemolysis syndrome and avascular necrosis in sickle cell disease patients amid the pandemic.
Understanding these interactions may inform future research directions and improve therapeutic strategies for affected populations.
Cite This Study
Martí-Carvajal et al. (2025) studied this question.